JLMC does NOT charge authors article submission fees and it does NOT charge article processing fees.
All the original research articles to be published in JLMC will be peer reviewed. JLMC adopts a double blind review policy. For those authored by a member of a journal’s editorial team, the editor will have no input or influence on the peer review process or publication decision for their own article.
Detail peer review policy can be found HERE.
All research articles submitted should include a letter from the Institutional review board/committee that the study obtained ethics approval.
Experimental research on human or any animals must comply with and conform to institutional, national, or international Good Clinical Practice guidelines.
Even when a study has been approved by a research ethics committee or institutional review board, editors may be worried about the ethics of the work. Editors may then ask authors for more detailed information such as:
If an article contains personal medical information including x-rays, photos etc, patient’s consent is necessary for publication of such details. If consent cannot be obtained for whatever reason, then JLMC will anonymise the details as much as possible.
All the personal details entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
All the competing interest related to the study should be acknowledged at the end of the main text before the references with a heading "Competing Interests".
A competing interest in medical publishing exists when a participant’s private interests compete with his or her responsibilities to the scientific community, readers, and society.
Types of competing interests includes but not limited to:
Examples of competing interests are
All sources of funding should be declared under the heading “Funding” at the end of the manuscript file (before the references).
Authors must describe the role of the sponsor(s), if any, in the study design; in the collection, analysis and interpretation of the data; in the writing of the report.
All materials published in JLMC are immediately and freely available to anyone in the world via the Internet, permitting any user to read, download, copy, distribute, print, search, or link to the full text of these articles, crawl them for indexing, pass them as data to software, or use them for any lawful purpose, without financial, legal or technical barriers.
The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution (CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
JLMC allows authors to retain copyright for their work without restrictions. Author retains the publishing rights provided that the original publication of the article is properly cited. JLMC only requires an exclusive licence to publish the article first in its journal in print and online.
The corresponding author should read and agree to the following statement before submission of the manuscript for publication,
In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:
We screen all manuscripts that are sent out for peer review for plagiarism. We submit them to a web-based tool (iThenticate). For minor plagiarism, as defined by COPE, we write to authors and discuss findings, request them to correct it and resubmit. For major plagiarism and other misconduct such as duplicate publication, data fabrication and data falsification, we explain that the misconduct is unacceptable and ask them to take responsibility by writing a letter of apology, reject the article and ban them for up to three year. If they refuse to do so, we may inform their institution and/or regulatory body in the country and inform them about the incident.
Authors are requested to inform the journal of any errors they have noticed (or have been informed of) in their article once published. Corrections are made at the journal's discretion. The correction procedure depends on the publication stage of the article:
Online First publication
The Online First (or ‘published ahead of print’) version is considered the version of record, and not an opportunity to make changes prior to print publication. JLMC will consider replacing this version with an updated version which corrects the error and notes that the change has been made (in a correction notice at the end of the article). The correction notice will be retained in the print version for record.
Publication in an issue
If the article has already appeared in an issue, a correction notice will be printed in the next available print issue. The online version of the article will link to the correction notice, and vice versa.
Most articles accepted for publication are published Online ahead of publication in a printed journal issue.
JLMC reserves the right to decline any submitted advertisement or to discontinue publication of any advertisement previously accepted.
Products or services closely related to medical practice, medical education, professional development, or health care delivery are eligible for advertising.
Consumer products and nonfinancial services that are offered by responsible advertisers and that are of interest to physicians may be eligible.
Drugs, medical devices, alcoholic beverages, and tobacco are not eligible for advertisement in JLMC.
Evaluate all articles to ensure the evidence readers need to evaluate the article’s conclusion.
Provide references to articles.
Provide author contact information.
Ensure authorship criteria are met.
Make all authors responsible for the content of their article.
Disclose all relevant conflict of interest.
Ensure that research and publication malpractices are neutralized.
Promote discussion on scientific merits of a paper.